Male Breast Carcinoma Active Not Recruiting Phase 3 Trials for Cefotaxime (DB00493)

IndicationStatusPhase
DBCOND0030384 (Male Breast Carcinoma)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs